Why Oura’s Sleep-Tracking Lawsuit Is Really About Trust
The case is reigniting questions about how much precision consumers should expect from AI-powered health wearables.
The case is reigniting questions about how much precision consumers should expect from AI-powered health wearables.
Epic faced an FTC antitrust probe this past week, but that didn't stop the EHR giant from unveiling a wave of new AI tools at its annual conference.
New executive research from Ari Kaplan explores how law firm leaders are responding to changing client expectations, evolving economics, talent transformation, and AI governance.
If you're interested in health law, you need to see this list.
It follows a public letter Senator Bill Cassidy sent to the AMA last year accusing it of ‘abus[ing] [its] government-backed monopoly by charging exorbitant fees to anyone using the CPT code set.’
A court ruling struck down key parts of how regulators calculate the No Surprises Act's qualifying payment amount, siding with the Texas Medical Association's argument that the formula has historically favored payers in arbitration.
Sangamo Therapeutics filed for Chapter 11 bankruptcy in June after its search for strategic alternatives failed to find a path forward for the company. PTC Therapeutics’ auction win brings a Sangamo gene therapy candidate for Fabry disease, a rare inherited disorder with few treatment options.
Grounded in authoritative content and verified at every step, Protégé is the only legal AI tool that delivers work you can trust—without exception.
A bipartisan group of six senators introduced a bill to reform the 340B drug program, locking in hospitals' use of contract pharmacies and adding new transparency and compliance rules. The legislation would also kill HHS' contested rebate pilot within a year and replace it with a national data clearinghouse to catch duplicate discounts.
A recommendation from a Centers for Disease Control and Prevention advisory committee is key for payer coverage, and that committee has not met all year due to ongoing litigation.
HHS is reviving a rebate program for 340B drug discounts after the previous pilot was blocked in court earlier this year.
The FTC and the states of Utah and California sued Hims & Hers, alleging it improperly shared consumers’ health information and misled customers about billing, subscriptions, and cancellations.
The company is emphasizing ‘white glove service’ in the AI era. Here’s what the initiative is delivering for clients.
As patients increasingly bring AI chatbot advice into exam rooms, where does liability land when that advice goes wrong? Health law attorney Meghan O'Connor said the answer still isn’t clear, but silence is the riskiest response for providers.
Rep. Angie Craig introduced a bill to establish a public health insurance option on the ACA marketplaces and permanently extend enhanced premium tax credits.
These three legal regimes are pulling in different directions, and the developers that navigate them well will be the ones that plan for all three from the start.
The House Ways and Means Committee unanimously advanced a bill to reform Medicare Advantage prior authorization requirements.
The Coalition Against Surprise Medical Billing launched a campaign opposing the No Surprises Act Enforcement Act, arguing it would worsen IDR process abuse.